What Researchers Did
Researchers investigated whether distortion product otoacoustic emissions (DPOAEs) could predict hearing outcomes in 78 patients with idiopathic sudden sensorineural hearing loss (ISSNHL) who received steroid and hyperbaric oxygen therapy.
What They Found
They found that patients with a hearing improvement rate of 50% or more had significantly larger net DPOAE amplitudes at f2 frequencies of 3031 and 4812Hz (p<0.05). A significant correlation was observed between hearing improvement and DPOAE amplitude at these frequencies, with correlation coefficients of 0.528 and 0.522, respectively.
What This Means for Canadian Patients
Measuring distortion product otoacoustic emissions (DPOAEs) could help predict hearing recovery in Canadian patients with idiopathic sudden sensorineural hearing loss. This may allow for more personalized treatment strategies, potentially guiding clinicians on which patients might benefit most from specific interventions.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants or researchers.
Study Limitations
A limitation of this study is its relatively small sample size of 78 patients, which may limit the generalizability of the findings.